Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review
Elena Calabria, Federica Canfora, Massimo Mascolo, et al.
Pathology - Research and Practice (2022) Vol. 232, pp. 153834-153834
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 77
Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review
Federica Di Spirito, Alessandra Amato, Maria Pia Di Palo, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10228-10228
Open Access | Times Cited: 31
Oral Lesions in Pediatric Subjects: SARS-CoV-2 Infection and COVID-19 Vaccination
Federica Di Spirito, Mario Caggiano, Maria Pia Di Palo, et al.
Applied Sciences (2022) Vol. 12, Iss. 18, pp. 8995-8995
Open Access | Times Cited: 27
Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey
Y Yamamura, Chisa Nakashima, N. Kagawa, et al.
Cureus (2025)
Open Access
Five cases of new‐onset pemphigus following vaccinations against coronavirus disease 2019
Alberto Corrà, Francesca Barei, Giovanni Genovese, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 2, pp. 229-233
Open Access | Times Cited: 18
New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies
Aref Ghanaatpisheh, Mohadesseh Safari, Hoda Haghshenas, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
The multifactorial complexities of autoimmune development in Pemphigus vulgaris: Critical evaluation of the role of environmental and lifestyle “exposome” factors
Olumayowa T. Adebiyi, Dominique F. Galloway, Michael S. Augustin, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Severe aggravation and possible triggering of pemphigus vulgaris following COVID-19 vaccination: report of two cases
Kinuko Irie, Toshiyuki Yamamoto
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 5, pp. 758-762
Open Access | Times Cited: 2
Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series
Timothy Cowan, Cheng Huang, Dédée F. Murrell
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 7
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review
Po‐Chien Wu, I‐Hsin Huang, Ching-Ya Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 465-465
Open Access | Times Cited: 2
Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies
Xueyi Huang, Xiaoqian Liang, Jiao Zhang, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3968-3968
Open Access | Times Cited: 11
IgA pemphigus following COVID-19 vaccination: A case report
Rafael Paolo Lansang, Esiahas Amdemichael, Dusan Sajic
SAGE Open Medical Case Reports (2023) Vol. 11
Open Access | Times Cited: 6
Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report
Naram Khalayli, Abdullah Omar, Mayssoun Kudsi
Journal of Medical Case Reports (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Pemphigus Foliaceus after COVID-19 Vaccination: A Report of Two Cases
Nguyen Nhat Pham, Thuy Thi Phan Nguyen, Thao Thi Phuong Vu, et al.
Case Reports in Dermatological Medicine (2023) Vol. 2023, pp. 1-6
Open Access | Times Cited: 5
Clinicopathological characteristics of cutaneous complications following COVID‐19 vaccination: A case series
Reem Diab, Azadeh Rakhshan, Sareh Salarinejad, et al.
Journal of Cosmetic Dermatology (2023) Vol. 23, Iss. 3, pp. 725-730
Open Access | Times Cited: 5
Pemphigus vulgaris following second dose of mRNA ‐( Pfizer‐BioNTech ) COVID‐19 vaccine
Fatima-Zahra Agharbi, G. Basri, S. Chiheb
Dermatologic Therapy (2022) Vol. 35, Iss. 10
Open Access | Times Cited: 9
New onset pemphigus foliaceus following AstraZeneca COVID‐19 vaccination
Mina Almasi‐Nasrabadi, Radha S Ayyalaraju, Ashish K. Sharma, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Open Access | Times Cited: 9
Pemphigus vulgaris and mucous membrane pemphigoid: A systematic review of clinical manifestations, diagnosis, and treatment
Hannah Gil de Farias Morais, SAMILY CORDEIRO DE OLIVEIRA, Maurília Raquel de Souto Medeiros, et al.
Journal of Stomatology Oral and Maxillofacial Surgery (2024) Vol. 125, Iss. 5, pp. 101960-101960
Closed Access | Times Cited: 1
New onset of pemphigus foliaceus following BBIBP COVID ‐19 vaccine
Mohammad Reza Pourani, Farahnaz Bidari‐Zerehpoosh, Azin Ayatollahi, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Open Access | Times Cited: 8
Two cases with new onset of pemphigus foliaceus after SARS‐CoV ‐2 vaccination
Jacem Rouatbi, A. Aounallah, M. Lahouel, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Open Access | Times Cited: 8
Cutaneous Adverse Events After COVID-19 Vaccination
Sinee Weschawalit, Padcha Pongcharoen, Worapop Suthiwartnarueput, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1473-1484
Open Access | Times Cited: 4
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
Nika Kianfar, Shayan Dasdar, Ali Salehi Farid, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review
Daniela Russo, Rossella Accarino, Silvia Varricchio, et al.
Pathology - Research and Practice (2022) Vol. 242, pp. 154300-154300
Open Access | Times Cited: 6
A severe relapse of pemphigus vulgaris after SARS‐CoV‐2 vaccination
Luigi Ligrone, Serena Lembo, Francesco Cillo, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top